JEFFREY MILLMAN
Architects in Cambridge, MA
License number
Massachusetts 3969
Expiration Date
Aug 31, 2008
Type
Architect
Address
Address
Cambridge, MA 02138
Personal information
See more information about JEFFREY MILLMAN at radaris.comName
Address
Phone
7 Berkeley Pl, Cambridge, MA 02138
7 Berkeley Pl, Cambridge, MA 02138
2 Acre Rd, Billerica, MA 01821
1 Acre Rd, Billerica, MA 01821
2 Acre Rd, Billerica, MA 01821
Organization information
See more information about JEFFREY MILLMAN at bizstanding.comJEFFREY MILLMAN ASSOC ARCHT
7 Berkeley Pl, Cambridge, MA 02138
Industry:
Architect
Phone:
(617) 234-3200 (Phone)
JEFFREY MILLMAN ASSOCIATES,INC
7 Berkeley Pl, Cambridge, MA 02138
Status:
Inactive
Registration:
Jan 1, 1980
Inactive since:
Nov 26, 2014
State ID:
042688651
Business type:
Domestic Profit Corporation
President:
Jeffrey Millman (President), 7 Berkeley Pl, Cambridge, MA (Physical)
Professional information
Postdoctoral Research Associate At Harvard University
Position:
Postdoctoral Research Associate at Harvard University
Location:
Greater Boston Area
Industry:
Research
Work:
Harvard University
- Cambridge, MA since Jul 2011
-
Postdoctoral Research Associate
MIT
- Cambridge, MA Jan 2006 - May 2011
-
Research Assistant
Education:
Massachusetts Institute of Technology 2005 - 2011
Ph.D., Chemical Engineering North Carolina State University 2001 - 2005
B.S., Chemical Engineering
Ph.D., Chemical Engineering North Carolina State University 2001 - 2005
B.S., Chemical Engineering
Methods And Compositions For Increased Safety Of Stem Cell-Derived Populations
US Patent:
2012021, Aug 30, 2012
Filed:
Jul 9, 2010
Appl. No.:
13/382965
Inventors:
Clark K. Colton - Newton MA, US
Jeffrey R. Millman - Cambridge MA, US
Jeffrey R. Millman - Cambridge MA, US
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61K 35/12, C12N 5/077, C12Q 1/02, C12N 5/071
US Classification:
424 937, 435325, 435377, 435 29
Abstract:
The invention provides methods and compositions relating to differentiated cell populations that derive from pluripotent stem cells. The methods relate to reducing the number of residual stem cells present in such populations. The compositions include differentiated cell populations that contain reduced number of stem cells or that contain no stem cells. Pluripotent stem cells may be reduced in number and/or function through exposure to low oxygen levels.
Methods And Compositions For Enhanced Differentiation From Embryonic Stem Cells
US Patent:
2010026, Oct 14, 2010
Filed:
Jun 13, 2008
Appl. No.:
12/664763
Inventors:
Clark K. Colton - Newton MA, US
Daryl Powers - Cambridge MA, US
Jeffrey R. Millman - Cambridge MA, US
Daryl Powers - Cambridge MA, US
Jeffrey R. Millman - Cambridge MA, US
Assignee:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY - CAMBRIDGE
International Classification:
C12N 5/02
US Classification:
435377
Abstract:
The invention provides methods for differentiating pluripotent stem cells such as ES cells with improved progenitor and differentiated cell yield using low oxygen conditions and optionally in the absence of exogenously added differentiation factors.